Obesity in heart failure: impact on survival and treatment modalities

References

• Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation 125(1), e2–e220 (2012).
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones D, Adams R, Carnethon M et al. Heart disease and stroke statistics – 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119(3), 480–486 (2009).
   PubMed Web of Science ®Google Scholar
• Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N. Engl. J. Med. 341(6), 427–434 (1999).
   PubMed Web of Science ®Google Scholar
• Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch. Intern. Med. 162(16), 1867–1872 (2002).
   PubMed Web of Science ®Google Scholar
• Rexrode KM, Hennekens CH, Willett WC et al. A prospective study of body mass index, weight change, and risk of stroke in women. Jama 277(19), 1539–1545 (1997).
   PubMed Web of Science ®Google Scholar
• Wang TJ, Parise H, Levy D et al. Obesity and the risk of new-onset atrial fibrillation. Jama 292(20), 2471–2477 (2004).
   PubMed Web of Science ®Google Scholar
• Kenchaiah S, Evans JC, Levy D et al. Obesity and the risk of heart failure. N. Engl. J. Med. 347(5) 305–313 (2002).
   PubMed Web of Science ®Google Scholar
• Kenchaiah S, Sesso HD, Gaziano JM. Body mass index and vigorous physical activity and the risk of heart failure among men. Circulation 119(1), 44–52 (2009).
   PubMed Web of Science ®Google Scholar
• Hu G, Jousilahti P, Antikainen R, Katzmarzyk PT, Tuomilehto J. Joint effects of physical activity, body mass index, waist circumference, and waist-to-hip ratio on the risk of heart failure. Circulation 121(2), 237–244 (2010).
   PubMed Web of Science ®Google Scholar
• Loehr LR, Rosamond WD, Poole C et al. Association of multiple anthropometrics of overweight and obesity with incident heart failure: the Atherosclerosis Risk in Communities study. Circ. Heart Fail. 2(1), 18–24 (2009).
   PubMed Web of Science ®Google Scholar
• Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am. J. Med. Sci. 321(4), 225–236 (2001).
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Milani RV, Ventura HO, Cardenas GA, Mehra MR, Messerli FH. Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am. J. Cardiol. 100(9), 1460–1464 (2007).
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Amodeo C, Ventura HO, Messerli FH. Left atrial abnormalities indicating diastolic ventricular dysfunction in cardiopathy of obesity. Chest 92(6), 1042–1046 (1987).
   PubMed Web of Science ®Google Scholar
• Chakko S, Mayor M, Allison MD, Kessler KM, Materson BJ, Myerburg RJ. Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity. Am. J. Cardiol. 68(1), 95–98 (1991).
   PubMed Web of Science ®Google Scholar
• Alpert MA, Terry BE, Mulekar M et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am. J. Cardiol. 80(6), 736–740 (1997).
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J. Am. Coll. Cardiol. 53(21), 1925–1932 (2009).
   PubMed Web of Science ®Google Scholar
• Morricone L, Malavazos AE, Coman C, Donati C, Hassan T, Caviezel F. Echocardiographic abnormalities in normotensive obese patients: relationship with visceral fat. Obes. Res. 10(6), 489–498 (2002).
   PubMedGoogle Scholar
• Kenchaiah S, Pocock SJ, Wang D et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 116(6), 627–636 (2007).
   PubMed Web of Science ®Google Scholar
• Ather S, Chan W, Bozkurt B et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J. Am. Coll. Cardiol. 59(11), 998–1005 (2012).
   PubMed Web of Science ®Google Scholar
• Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J. Am. Coll. Cardiol. 38(3), 789–795 (2001).
   PubMed Web of Science ®Google Scholar
• Bozkurt B, Deswal A. Obesity as a prognostic factor in chronic symptomatic heart failure. Am. Heart J. 150(6), 1233–1239 (2005).
   PubMed Web of Science ®Google Scholar
• Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am. Heart J. 153(1), 74–81 (2007).
   PubMed Web of Science ®Google Scholar
• Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am. Heart J. 156(1), 13–22 (2008).
   PubMed Web of Science ®Google Scholar
• Clark AL, Fonarow GC, Horwich TB. Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J. Card. Fail. 17(5), 374–380 (2011).
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am. J. Cardiol. 91(7), 891–894 (2003).
   PubMed Web of Science ®Google Scholar
• Futter JE, Cleland JG, Clark AL. Body mass indices and outcome in patients with chronic heart failure. Eur. J. Heart Fail. 13(2), 207–213 (2011).
   PubMed Web of Science ®Google Scholar
• Ingelsson E, Sundstrom J, Arnlov J, Zethelius B, Lind L. Insulin resistance and risk of congestive heart failure. JAMA 294(3), 334–341 (2005).
   PubMed Web of Science ®Google Scholar
• Voulgari C, Tentolouris N, Dilaveris P, Tousoulis D, Katsilambros N, Stefanadis C. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. J. Am. Coll. Cardiol. 58(13), 1343–1350 (2011).
   PubMed Web of Science ®Google Scholar
• Bahrami H, Bluemke DA, Kronmal R et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J. Am. Coll. Cardiol. 51(18), 1775–1783 (2008).
   PubMed Web of Science ®Google Scholar
• Frankel DS, Vasan RS, D’Agostino RB Sr et al. Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J. Am. Coll. Cardiol. 53(9), 754–762 (2009).
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease: does leptin have a role? J. Am. Coll. Cardiol. 58(18), 1870–1877 (2011).
   PubMed Web of Science ®Google Scholar
• Beatty AL, Zhang MH, Ku IA, Na B, Schiller NB, Whooley MA. Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study. Atherosclerosis 220(2), 587–592 (2012).
   PubMed Web of Science ®Google Scholar
• Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 121(6), 2111–2117 (2011).
   PubMed Web of Science ®Google Scholar
• von Haehling S, Horwich TB, Fonarow GC, Anker SD. Tipping the scale: heart failure, body mass index, and prognosis. Circulation 116(6), 588–590 (2007).
   PubMed Web of Science ®Google Scholar
• Taylor JA, Christenson RH, Rao K, Jorge M, Gottlieb SS. B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am. Heart J. 152(6), 1071–1076 (2006).
   PubMed Web of Science ®Google Scholar
• Horwich TB, Hamilton MA, Fonarow GC. B-type natriuretic peptide levels in obese patients with advanced heart failure. J. Am. Coll. Cardiol. 47(1), 85–90 (2006).
   PubMed Web of Science ®Google Scholar
• Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV. The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J. Am. Coll. Cardiol. 36(7), 2126–2131 (2000).
   PubMed Web of Science ®Google Scholar
• Aquilani R, Opasich C, Verri M et al. Is nutritional intake adequate in chronic heart failure patients? J. Am. Coll. Cardiol. 42(7), 1218–1223 (2003).
   PubMed Web of Science ®Google Scholar
• Anker SD, Ponikowski P, Varney S et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349(9058), 1050–1053 (1997).
   PubMed Web of Science ®Google Scholar
• Pasini E, Aquilani R, Gheorghiade M, Dioguardi FS. Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach. Ital. Heart J. 4(4), 232–235 (2003).
   PubMedGoogle Scholar
• Rauchhaus M, Koloczek V, Volk H et al. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int. J. Cardiol. 76(2–3), 125–133 (2000).
   PubMed Web of Science ®Google Scholar
• Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipoprotein hypothesis. Lancet 356(9233), 930–933 (2000).
   PubMed Web of Science ®Google Scholar
• Kistorp C, Faber J, Galatius S et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112(12), 1756–1762 (2005).
   PubMed Web of Science ®Google Scholar
• Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323(4), 236–241 (1990).
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J. Am. Coll. Cardiol. 43(8), 1439–1444 (2004).
   PubMed Web of Science ®Google Scholar
• Mehra MR, Kobashigawa J, Starling R et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates–2006. J. Heart. Lung. Transplant. 25(9), 1024–1042 (2006).
   PubMed Web of Science ®Google Scholar
• Fasol R, Schindler M, Schumacher B et al. The influence of obesity on perioperative morbidity: retrospective study of 502 aortocoronary bypass operations. Thorac. Cardiovasc. Surg. 40(3), 126–129 (1992).
   PubMed Web of Science ®Google Scholar
• Birkmeyer NJ, Charlesworth DC, Hernandez F et al. Obesity and risk of adverse outcomes associated with coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 97(17), 1689–1694 (1998).
   PubMed Web of Science ®Google Scholar
• Lietz K, John R, Burke EA et al. Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation 72(2), 277–283 (2001).
   PubMed Web of Science ®Google Scholar
• Grady KL, White-Williams C, Naftel D et al. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group. J. Heart Lung Transplant. 18(8), 750–763 (1999).
   PubMed Web of Science ®Google Scholar
• Grady KL, Naftel D, Pamboukian SV et al. Post-operative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: multi-institutional study of post-operative weight change. J. Heart Lung Transplant. 24(9), 1424–1430 (2005).
   PubMed Web of Science ®Google Scholar
• Stehlik J, Edwards LB, Kucheryavaya AY et al. The registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report–2012. J. Heart Lung Transplant. 31(10), 1052–1064 (2012).
   PubMed Web of Science ®Google Scholar
• Russo MJ, Hong KN, Davies RR et al. The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines? Ann. Surg. 251(1), 144–152 (2010).
   PubMed Web of Science ®Google Scholar
• Feldman D, Pamboukian SV, Teuteberg JJ et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summary. J. Heart Lung Transplant. 32(2), 157–187 (2013).
   PubMed Web of Science ®Google Scholar
• Raymond AL, Kfoury AG, Bishop CJ et al. Obesity and left ventricular assist device driveline exit site infection. ASAIO J. 56(1), 57–60 (2010).
   PubMed Web of Science ®Google Scholar
• Zahr F, Genovese E, Mathier M et al. Obese patients and mechanical circulatory support: weight loss, adverse events, and outcomes. Ann. Thorac. Surg. 92(4), 1420–1426 (2011).
   PubMed Web of Science ®Google Scholar
• Musci M, Loforte A, Potapov EV et al. Body mass index and outcome after ventricular assist device placement. Ann. Thorac. Surg. 86(4), 1236–1242 (2008).
   PubMed Web of Science ®Google Scholar
• Butler J, Howser R, Portner PM, Pierson RN 3rd. Body mass index and outcomes after left ventricular assist device placement. Ann. Thorac. Surg. 79(1), 66–73 (2005).
   PubMed Web of Science ®Google Scholar
• Brewer RJ, Lanfear DE, Sai-Sudhakar CB et al. Extremes of body mass index do not impact mid-term survival after continuous-flow left ventricular assist device implantation. J. Heart Lung Transplant. 31(2), 167–172 (2012).
   PubMed Web of Science ®Google Scholar
• Lietz K, Long JW, Kfoury AG et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116(5), 497–505 (2007).
   PubMed Web of Science ®Google Scholar
• Cowger J, Sundareswaran K, Rogers JG et al. Predicting Survival in Patients Receiving Continuous Flow Left Ventricular Assist Devices: The HeartMate II Risk Score. J. Am. Coll. Cardiol. 61(3), 313–321 (2013).
   PubMed Web of Science ®Google Scholar
• Garza CA, Pellikka PA, Somers VK et al. Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity. Am. J. Cardiol. 105(4), 550–556 (2010).
   PubMed Web of Science ®Google Scholar
• Rider OJ, Francis JM, Ali MK et al. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J. Am. Coll. Cardiol. 54(8), 718–726 (2009).
   PubMed Web of Science ®Google Scholar
• Owan T, Avelar E, Morley K et al. Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity study. J. Am. Coll. Cardiol. 57(6), 732–739 (2011).
   PubMed Web of Science ®Google Scholar
• Anker SD, Negassa A, Coats AJ et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361(9363), 1077–1083 (2003).
   PubMed Web of Science ®Google Scholar
• Pocock SJ, McMurray JJ, Dobson J et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur. Heart J. 29(21), 2641–2650 (2008).
   PubMed Web of Science ®Google Scholar
• Evangelista LS, Heber D, Li Z, Bowerman S, Hamilton MA, Fonarow GC. Reduced body weight and adiposity with a high-protein diet improves functional status, lipid profiles, glycemic control, and quality of life in patients with heart failure: a feasibility study. J. Cardiovasc. Nurs. 24(3), 207–215 (2009).
   PubMed Web of Science ®Google Scholar
• Pritchett AM, Deswal A, Aguilar D et al. lifestyle modification with diet and exercise in obese patients with heart failure – a pilot study. J. Obes. Weight Loss Ther. 2(2), 1–8 (2012).
   PubMedGoogle Scholar
• O’Connor CM, Whellan DJ, Lee KL et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301(14), 1439–1450 (2009).
   PubMed Web of Science ®Google Scholar
• Flynn KE, Pina IL, Whellan DJ et al. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301(14), 1451–1459 (2009).
   PubMed Web of Science ®Google Scholar
• Horwich TB, Broderick S, Chen L et al. Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure. Am. J. Cardiol. 108(12), 1754–1759 (2011).
   PubMed Web of Science ®Google Scholar
• Heck AM, Yanovski JA, Calis KA. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 20(3), 270–279 (2000).
   PubMed Web of Science ®Google Scholar
• Beck-da-Silva L, Higginson L, Fraser M, Williams K, Haddad H. Effect of Orlistat in obese patients with heart failure: a pilot study. Congest. Heart Fail. 11(3), 118–123 (2005).
   PubMedGoogle Scholar
• Smith SR, Weissman NJ, Anderson CM et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N. Engl. J. Med. 363(3), 245–256 (2010).
   PubMed Web of Science ®Google Scholar
• Ashrafian H, le Roux CW, Darzi A, Athanasiou T. Effects of bariatric surgery on cardiovascular function. Circulation 118(20), 2091–2102 (2008).
   PubMed Web of Science ®Google Scholar
• Ramani GV, McCloskey C, Ramanathan RC, Mathier MA. Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin. Cardiol. 31(11), 516–520 (2008).
   PubMed Web of Science ®Google Scholar
• McCloskey CA, Ramani GV, Mathier MA et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg. Obes. Relat. Dis. 3(5), 503–507 (2007).
   PubMed Web of Science ®Google Scholar
• Dhesi P, Simsir SA, Daneshvar D, Rafique A, Phan A, Schwarz ER. Left ventricular assist device as ‘bridge to weight loss’ prior to transplantation in obese patients with advanced heart failure. Ann. Transplant. 16(1), 5–13 (2011).
   PubMedGoogle Scholar
• Thompson K, Dhesi P, Nguyen D, Czer L, Moriguchi J, Schwarz E. Evaluation of the HeartMate II left ventricular assist device in obese heart failure patients: effects on weight loss. Ann. Transplant. 16(2), 63–67 (2011).
   PubMedGoogle Scholar
• Gill RS, Karmali S, Nagandran J, Frazier HO, Sherman V. Combined Ventricular Assist Device Placement With Adjustable Gastric Band (VAD-BAND): a promising new technique for morbidly obese patients awaiting potential cardiac transplantation. J. Clin. Med. Res. 4(2), 127–129 (2012).
   PubMedGoogle Scholar
• McCloskey CA, Ramani GV, Mathier MA et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg. Obes. Relat. Dis. 3(5), 503–507 (2007).
   PubMed Web of Science ®Google Scholar
• Ramani GV, McCloskey C, Ramanathan RC, Mathier MA. Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin. Cardiol. 31(11), 516–520 (2008).
   PubMed Web of Science ®Google Scholar